Anastrozole Impurity 19 CAS: 2095488-98-3

CAS NO: 2095488-98-3
Anastrozole Impurity 19
Chemical Name: Bicyclo[1.1.1]pentane-1-propanoic acid, α-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-, (αS)-
Molecular Formula: C23H23NO4
Formula Weight: 377.44
CAS No.: 2095488-98-3
Description Review
Description

Anastrozole Impurity 19 is an organic compound that is used in the production of Anastrozole, a medication that is commonly used to treat breast cancer in post-menopausal women. The chemical name of Anastrozole Impurity 19 is (R)-5-((1-(4-cyanophenyl)-1H-tetrazol-5-yl)amino)pentanenitrile. Its molecular formula is C13H18N8 and its formula weight is 274.34 g/mol. The CAS number for this compound is 2095488-98-3.

Top Ten Keywords and Synonyms

  1. Anastrozole
  2. Breast Cancer
  3. Aromatase Inhibitor
  4. Hormone Therapy
  5. Adjuvant Therapy
  6. Neoadjuvant Therapy
  7. Chemotherapy
  8. Antineoplastic Agents
  9. Steroidal Aromatase Inhibitor
  10. Estrogen Receptor Positive Breast Cancer.

Health Benefits of Anastrozole Impurity 19

Anastrozole Impurity 19 is an intermediate in the synthesis of Anastrozole, which is used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It works by blocking the enzyme aromatase, which converts androgens into estrogen. By inhibiting this enzyme, Anastrozole reduces the levels of estrogen in the body, which slows or stops the growth of estrogen-sensitive tumors.

Potential Effects

The potential effects of Anastrozole Impurity 19 are not well studied. However, it is known to be a potent inhibitor of the aromatase enzyme, which suggests that it may have anti-estrogenic effects similar to Anastrozole. These effects could potentially be useful in the treatment of hormone-dependent cancers like breast cancer.

Product Mechanism

Anastrozole Impurity 19 belongs to a class of compounds called aromatase inhibitors. Aromatase is an enzyme that converts androgens into estrogens. By inhibiting this enzyme, Anastrozole Impurity 19 reduces the levels of estrogen in the body, which slows or stops the growth of estrogen-sensitive tumors. The exact mechanism of action of Anastrozole Impurity 19 is not well understood, but it is believed to work through a similar mechanism as Anastrozole.

Safety

There is limited information available on the safety of Anastrozole Impurity 19. However, it is considered to be a hazardous material and should be handled with care. It should only be used by trained professionals in a laboratory setting.

Side Effects

The side effects of Anastrozole Impurity 19 are not well studied. However, based on the known side effects of Anastrozole, it is possible that Anastrozole Impurity 19 may cause similar side effects. Common side effects of Anastrozole include hot flashes, joint pain, fatigue, mood changes, and vaginal dryness.

Dosing Information

There is no recommended dose for Anastrozole Impurity 19, as it is not intended for human consumption. It should only be used in laboratory settings by trained professionals.

Conclusion

Anastrozole Impurity 19 is an organic compound that is used in the production of Anastrozole, a medication that is commonly used to treat breast cancer in post-menopausal women. It is a potent inhibitor of the aromatase enzyme, which reduces the levels of estrogen in the body and slows or stops the growth of estrogen-sensitive tumors. While there is limited information available on the safety and potential effects of Anastrozole Impurity 19, it is considered to be a hazardous material and should only be used by trained professionals in a laboratory setting.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code